Often working closely with the firm’s IP and commercial offerings, and also able to leverage the US network, Brown Rudnick LLP‘s venture team provides ’sensible and measured solutions’ to investors and investees in domestic and cross-border transactions at every stage of the corporate life cycle. Team head Neil Foster ‘values simplicity over making things overly complex’ and is a popular choice among funders and start-ups in the technology and media spaces, as well as more recently a growing amount of energy transition matters. As part of his broad corporate and capital markets offering, UK and US-qualified partner Mark Dorff regularly handles tech and life sciences-related venture matters and has particular expertise advising European clients on US investments. Sage Revell, who was promoted to partner in February 2023, is also key member of the team, particularly in the context of life sciences venture mandates.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

'The team provides sensible and measured solutions.'
'Neil Foster and Tim Davison are outstanding.'
'Neil Foster values simplicity over making things overly complex.'
'They know our business and the industries we work in well and are able to tailor their responses appropriately for us. Their knowledge of and expertise in their respective fields is exemplary. Perhaps best of all, they are easy to deal with and have become welcome extensions to our team.'
'The Brown Rudnick London office understand what businesses want from their legal advisers: high quality advice that is framed in a commercial context that is not simply a description of the legislation itself but is delivered so that informed decisions can be taken quickly and accurately.'
'They want to get deals done, not find barriers to prevent them.'

Key clients

GB News
mOm Incubators
Capricorn Sustainable Chemistry Fund
Caelum Capital
Bio-Rad Laboratories, Inc
IONATE Limited
Coinfirm
Dermaliq
Highland Europe (UK) LLP (“Highland Capital”)
Pimentae
Japan Energy Fund
Deepbridge Capital
Chlesfield
ABB Technology Ventures
Sasol Chemicals
Iceotope Group Ltd

Work highlights

Closed a £50m Series B funding round for All Perspectives Limited (trading as “GB News”).
Acted as corporate legal counsel for Highland Capital in respect of their role as lead investor for the £40m Series B fundraise by RedSift Limited.
Represented Dermaliq Therapeutics, Inc., an independent private pharmaceutical company that was spun out from Novaliq GmbH in Germany, in connection with its $15m Series A round financing.